Background. To test the feasibility of percutaneous deployment of intracoronary polymeric stents, a prototype polyethylene terephthalate (PET) stent and a catheter-based delivery system were developed.
Percutaneous Polymeric Stents in Porcine Coronary Arteries
Initial Experience With Polyethylene Terephthalate Stents Joseph G. Murphy, MD; Robert S. Schwartz, MD; William D. Edwards, MD; Allan R. Camrud, RN; Ronald E. Vlietstra, MB,ChB; and David R. Holmes Jr., MD Background. To test the feasibility of percutaneous deployment of intracoronary polymeric stents, a prototype polyethylene terephthalate (PET) stent and a catheter-based delivery system were developed.
Methods and Results. Polymeric stents were deployed in the coronary arteries of 11 Yucatan swine: six stents were placed in the left anterior descending coronary artery, four stents were placed in the circumflex artery, and one stent was placed in the right coronary artery. Stent deployment was achieved by withdrawal of an outer delivery sheath, thus allowing the PET stent to self-expand to a preformed configuration. Two animals died during surgery, one during stent placement and the other several hours after implantation due to intracoronary thrombus formation. Two animals were electively sacrificed within 24 hours of stent implant to examine the adequacy of stent deployment within the coronary vessel. The remaining seven animals survived until the termination of the study 4-6 weeks later. Light microscopic examination of the stented vessels showed an extensive neointimal proliferative response with vessel occlusion in all animals who survived initial stent placement. There were two distinct types of histological responses to the PET stenta chronic foreign body inflammatory response around the stent tines and a neointimal proliferative response in the center of the occluded vessel lumen. The histological response seen in the central area of the vessel was morphologically similar to that seen in patients with restenosis after successful percutaneous transluminal coronary angioplasty, whereas the morphological response seen at the periphery of the stent tine was similar to that exhibited by a chronic foreign body reaction and was not typical of that seen in a restenosis lesion. A ventricular aneurysm also developed in the area of myocardium that was previously supplied by the occluded vessel.
Conclusions. This study demonstrates that percutaneous deployment of polymeric stents in the coronary arteries is technically feasible. The use of PET polymer was associated with an intense proliferative neointimal response that resulted in complete vessel occlusion. Histological examination of the stented segments of the vessel revealed no evidence that dissection of the vessel wall had occurred at the time of initial stent deployment. Although the PET polymer was of similar quality to that used in the manufacture of balloon angioplasty catheters, a toxic chemical or contaminant effect cannot be completely excluded as the stimulus to intimal proliferation. This finding may have relevance to the selection of materials for use as intravascular devices. (Circulation 1992;86:1596-1604) KEY WoRDs * stent * coronary restenosis * ventricular aneurysm P ercutaneous implantation of metallic stents in the coronary vessels was first reported in humans in 1987 by Sigwart et al.' Despite the high initial success rate, early and late complications have been reported with all current metallic stent designs.2-5 These problems include acute stent occlusion due to thrombus formation and restenosis due to intimal proliferation through the stent meshwork. Compared with stainless-steel or tantalum stents, polymeric stents have the potential to be biodegradable and/or drug eluting.
To test the hypothesis that percutaneous placement of polymeric stents was technically feasible, we developed a polyethylene terephthalate (PET) intracoronary stent and a specially adapted catheter-based delivery system. We report the successful deployment of percutaneous intracoronary polymeric stents in 11 Yucatan swine. Seven animals survived until the termination of the study 4-6 weeks after stent implant.
Methods Animals
All studies were conducted with the approval of and adherence to the ethical guidelines of the Mayo Clinic Animal Care and Use Committee.
The histological features of swine coronary arteries are similar to those of human coronary arteries, and the development of spontaneous atherosclerotic lesions is well documented in the pig.6,7 FIGURE 1. Photograph ofself-expanding biostablepolymeric stent. The stent was mounted within a delivery sheath (top) that was withdrawn. After self-expansion, the delivery catheter was removed, leaving the expanded meshwork stent (bottom) in place.
Pigs (weight, 40-50 kg) were fed a standard natural grain diet without lipid or cholesterol supplementation throughout the study.
Procedure
The carotid artery was used for arterial access in all animals. A midline incision was made in the ventral area of the neck after infiltration with 1% xylocaine. General anesthesia was induced with intramuscular ketamine (12 mg/kg) and xylazine (8 mg/kg). Continuous ECG monitoring and ear oximetry were performed throughout the procedure. The right external carotid artery was surgically exposed, and an 8F intra-arterial sheath was placed over a 0.035-in. tight J wire. Heparin (400 USP units/kg) was administered intravenously as a bolus. The carotid approach was chosen over the femoral approach because of the lower occurrence of postoperative hematoma formation, which is common after administration of a large dose of heparin following a femoral arteriotomy in swine.
The coronary artery was engaged using standard techniques with an 8F angioplasty guide catheter under fluoroscopic visualization. The unconstrained stent diameter was 2.5 mm, and the length was 2.0 cm. The delivery sheath was made from commercially available polypropylene tubing with an internal diameter of 1.4 mm and wall thickness of 0.3 mm to give an outside diameter of 2.0 mm. The filament mesh was 12 filaments per centimeter length, and the individual filaments were approximately 0.12 mm in diameter. The expandability ratio (ratio of expanded diameter to collapsed diameter) was 1.79.
The polymeric stent was loaded into the specially designed delivery catheter just before deployment. This was done to avoid stent distortion due to polymeric cold flow, which occurs when a polymeric stent is maintained in a contracted configuration for an extended period of time. The stent deployment catheter was advanced into the left anterior descending coronary, circumflex, or right coronary artery, as per protocol. The stents remained in their contracted configuration within an outer delivery sheath until the time of deployment (Figure 1 ). All stents were deployed in the main vessel trunk away from branch points or areas where the vessel tapered rapidly. For stent deployment, the outer delivery sheath was withdrawn so that the stent could self-expand within the coronary vessel ( Figure 2 ).
Injection of contrast medium 15 minutes after the procedure confirmed acute vessel patency in all animals without evidence of filling defects, vessel wall dissection, or distal coronary spasm. The carotid arteriotomy was repaired using standard technique or ligated if repair was not feasible, and the neck incision was closed with interrupted sutures. The animals were returned to a postoperative recovery area and observed. No antiplatelet agent or additional anticoagulants were administered subsequent to the initial bolus of heparin.
Histopathology
Seven pigs were sacrificed with intravenous injections of barbiturate and potassium chloride 4-6 weeks after stent implantation. Hearts were pressure-perfused for 24 hours with 10% neutral buffered formalin. Segments of coronary arteries that contained the polymeric stents were easily identified by transilluminating the entire vessel after removal from the heart using a powerful light source. In addition, it was frequently possible to palpate the polymeric stent tines within the coronary vessel at the time of histological dissection. These segments were removed from the heart, with at least 1 cm of normal vessel proximal and distal to the stent. The stent filaments were removed (so as not to distort or damage the artery) after the vessel was cross sectioned at 2-3-mm intervals. Sections from each arterial segment were stained with hematoxylin and eosin and with Lawson's elastic-van Gieson stains.
Results
Eleven animals underwent successful polymeric stent implantation ( Table 1 ). All had patent vessels (determined by angiography) 15 minutes after stent implant ( Figure 3 ). Seven animals survived until the termination of the study 4-6 weeks after implantation. Two animals died during surgery -one due to vessel occlusion secondary to an intimal dissection caused by trauma from the stent delivery catheter and the other several hours after stent implantation due to thrombus formation in the stent. There was no intimal dissection, and the stent was correctly deployed. Two animals were sacrificed within 24 FIGURE 2. Photograph ofpolyethylene delivery sheath, polyethylene terephthalate stent in contracted configuration, and metallic expulsion rod as seen from left to right. The expulsion rod was used to expel the stent as the delivery sheath was withdrawn.
hours after stent implant to confirm the correct mechanical deployment of the stent within the coronary vessel.
All animals that were sacrificed 4-6 weeks after stent implant had vessel occlusion at the site of stent deployment ( Figure 4 ). Light microscopy showed that vessel occlusion was due to neointimal proliferation at the site of stent implantation ( Figure 5A ). Two histological patterns were seen: a chronic foreign body inflammatory response with lymphocytes, eosinophils, and giant cells surrounding the stent filaments ( Figure SB ) and a marked neointimal proliferative response ( Figure 6A ) in the center of the vessel. The neointimal proliferative response was morphologically similar to that seen in human restenotic tissue obtained at the time of directional atherectomy or autopsy. The neointimal proliferation in the center of the vessel was histologically distinct from the chronic inflammation and was of smooth muscle cell origin, as established by positive staining for actin ( Figure 6B ). Electron microscopy also confirned the presence of contractile elements (a feature of smooth muscle cells and myofibroblasts) in these cells. Vessel occlusion by proliferative neointima occurred in all seven animals.
An unexpected finding was the development of postinfarction ventricular aneurysms in all animals sacrificed 4-6 weeks after stent implant ( Figure 7A) . A cross section of the aneurysmal wall showed replacement of ventricular muscle by scar tissue (Figure 7B) . The pig has not previously been recognized as an experimental model for post-myocardial infarct ventricular aneurysm formation.
Discussion
This study demonstrated the technical feasibility, at least in the short term, of implantation of polymeric stents in coronary vessels. Complete vessel occlusion by neointima occurred in all animals surviving to elective sacrifice. Ventricular aneurysm formation was an unexpected late finding probably induced by the PET material of which the stent was composed. Other polymers may not incite a similar reaction.
Acute stent occlusion due to thrombus formation has been a significant limiting factor in the development of intravascular metallic stents. In an early study with the metallic Wallsten stent, there was partial or complete stent occlusion by thrombus in 13 of 43 animals.3 In our study, no antiplatelet agents and no anticoagulants were administered with the exception of a single periprocedural bolus of heparin. In all animals (with one exception), there was no evidence of acute occlusive intravascular thrombus formation.
An important point in this study is whether insufficient expansile force was applied to the polymeric stent that would thus render the device in an intraluminal position and therefore an obstructive and highly thrombogenic position. There were three reasons for believing that this was not so. First, angiography performed 15 minutes after stent implant showed the vessel to be widely patent without evidence of an obstructive intraluminal thrombus. The polymeric stent material itself was not visible by radiographic means, but there was no indirect evidence to suggest thrombus formation within the device. Second, it has been our experience, when using metallic stents in porcine coronary arteries, that incomplete deployment of the stent that resulted in the formation of an acute obstructive thrombus always caused animal death due to ventricular fibrillation. This finding has also been noted by other investigators and probably results from the absence of any significant collateral circulation in the porcine model. Thus, it can be inferred that if animal survival occurred in the short term, an acute obstructive thrombus was almost certainly not present. Third, the position of the stent tines can be seen on the final histological sections of all vessels. In these sections, the holes where the stent tines had been placed can be seen to be subadjacent to the Thus, in summary, the final histological pattern of the stent tines as seen at the time of being sacrificed, the fact that the animals survived to elective death, and the angiographic pattern immediately after stent implantation strongly support the argument that adequate stent expansion did occur and that the stent had not been improperly or incompletely expanded (which would have rendered it obstructive and highly thrombogenic). Equally, there was no evidence that overexpansion of the stent occurred at the time of implant. First, the radial expansive force of a polymeric stent is low and would probably not be capable of resulting in a medial Second, no evidence of medial dissection was seen at the time of final histological examination despite complete histological examination of all stented segments in all animals surviving to elective death 4-6 weeks after implantation. Stent flexibility is a necessary prerequisite for successful intracoronary deployment because acute angles within the coronary tree must be negotiated. Delivery of metallic stents -even the articulated variantis significantly limited by its lack of flexibility. The polymeric stent is highly flexible and not limited in this regard. In addition, a recent modification of the polymeric stent delivery system has enabled us to now use an over-thewire delivery configuration.
PET (Dacron, Du Pont Co.) was chosen for initial study because of its widespread use in angioplasty balloon material and its ready availability. The biocompatibility of Dacron vascular grafts has been extensively studied.8 After graft implantation, leukocytes (principally neutrophils and monocytes) migrate to the graft site. The leukocyte infiltration persists for several days to weeks; then, the neutrophils disappear. The monocytes may transform into tissue macrophages in an attempt to remove foreign graft material. Lymphocytes may also be seen but are not considered important in graft incorporation. The intimal proliferation elicited by PET stents was associated with both a pronounced chronic foreign body inflammatory reaction around the individual stent filaments and extensive smooth muscle proliferation. The development of marked neointimal proliferation in response to a PET stent suggests a possible chemical as well as a mechanical stimulus for intimal proliferation after percutaneous transluminal coronary angioplasty (PTCA), possibly even from the PTCA balloon surface itself. Elucidation of the mechanism of PET-induced intimal proliferation may serve to explain certain aspects of the mechanism of human restenosis after angioplasty.
Animal Models of Postangioplasty Restenosis
Efforts to prevent human restenosis have been hampered by the lack of an accurate and easily reproducible animal model of neointimal proliferation. This PET restenosis model is different from other models of restenosis in that neointimal formation is notinduced by deep arterial injury and is unassociated with known lipid abnormalities. The architecture of the media of the vessel wall is preserved relatively intact with minimal apparent damage to the internal elastic lamina. Previously used animal models of restenosis have concentrated on the atheromatous nature of the experimental lesions,9"10 on deep arterial injury, and on damage to the media. Sanborn et all' used rabbits fed atherogenic diets with serum cholesterol levels frequently exceeding 1,000 mg/dl. In addition to intimal thickening, the resulting atheromatous lesions of the aorta, iliac, and femoral vessels contained large numbers of foam cells, not typical of human restenotic tissue and not seen in our animals.
Steele et al12 reported a model for restenosis using pig carotid arteries after endothelial denudation with the formation of thrombus and subsequent neointimal proliferation. Carotid and iliac arteries contain relatively more elastic fibers and proportionately less smooth muscle than coronary vessels and may be unsuitable as a model for human coronary restenosis because smooth muscle proliferation probably is a major factor in the genesis of the restenotic lesion.
The animals used in this study were fed a nonatherogenic diet. Histology resembling restenotic morphology without hyperlipidemia supports the concept that restenosis is a process independent of atherosclerosis. Although the proliferative effects might have been promoted further with a high-cholesterol diet, hyperlipidemia is clearly not a necessary condition for production of the proliferative response in this model. In this regard, it is important to emphasize that the microscopic coronary anatomy and intimal proliferation seen in these Yucatan swine were virtually identical to that previously described in human restenosis lesions.
Aneurysm Formation After Myocardial Infarction
Left ventricular aneurysm develops over a period of 2-8 weeks in 10-30% of patients after myocardial infarction.1314 Current experimental models of postinfarction ventricular aneurysm require a surgical approach with excision of a portion of the ventricular wall and the insertion of a Dacron patch to simulate a ventricular aneurysm.15"6 Dacron is a multifilament yarn composed of small continuous filaments of PET. After implantation of a Dacron patch, a fibrin layer approximately c 1 mm in thickness forms on the luminal surface of the graft. This is replaced within days to weeks by fibrous tissue that originates from the vasculature and grows through the interstices of the prosthesis.17 Such an experimental model has major theoretical and practical limitations. First, a thoracotomy with cardiopulmonary bypass is necessary with its attendant animal wastage. Second, insertion of a Dacron patch results in distortion of the normal ventricular anatomy. In contrast, in the pig model there is less anatomic distortion of the ventricle, with aneurysm formation due to loss of muscle with the resultant development of a full-thickness fibrotic scar in a manner similar to that of the postinfarct patient.
This model of ventricular aneurysm formation can be generated using regional anesthesia and sedation with a catheter-based technique and avoids the need for a thoracotomy and cardiopulmonary bypass. Ventricular aneurysms developed in all animals maintained for 4-6 weeks after stent implantation. The coronary anatomy of pigs is similar to that of humans in regard to histological structure, pattern of large vessel branching, and absence of significant preformed collateral vessels at the arterial level. The development of a relatively simple, inexpensive, and reproducible model for ventricular aneurysm after myocardial infarction is valuable and may aid the study of human postinfarction ventricular aneurysm formation.
Conclusions
We report the technical feasibility of percutaneous transluminal intracoronary deployment of polymeric stents. PET possesses the necessary mechanical properties for use as a stent but is unsuitable for human use because of the intense inflammatory and neointimal proliferative response elicited in this animal model. The PET model of coronary neointimal proliferation is unique and has not previously been reported.
We conclude that on the basis of immunohistochemical staining and transmission electron microscopy, vessel occlusion was due to smooth muscle cell neointimal proliferation. Polymeric stents, while having major potential advantages over metallic stents including biodegradability and drug-elution properties, may also be powerful inducers of neointimal proliferation. Although this study demonstrated that polymers can be configured in an appropriate design for intercoronary delivery, significant biomaterial problems exist before polymeric stents are ready for human investigation.
